Literature DB >> 7295462

Direct measurement of chlormethiazole extraction by liver, lung and kidney in man.

L E Mather, W B Runciman, A H Ilsley, K R Thomson, A R Goldin.   

Abstract

1 Chlormethiazole was used as a basal sedative for patients undergoing angiographic procedures. 2 Blood samples were drawn opportunistically to examine chlormethiazole extraction across liver, lungs and kidney. 3 Extraction across liver was typically 70-80% and apparently unrelated to input concentrations. Evidence for extraction across lung and kidney was inconclusive but these could each be approximately 20%. 4 Pharmacokinetics of chlormethiazole derived from compartment models were in accord with previous reports and were characterised by a high total body clearance (1-1.5 l/min). 5 Postural changes associated with the radiological procedures caused fluctuating blood concentrations which appear as noise in curve fitting procedures. 6 Pharmacokinetic properties derived from compartment theory cannot cope with these perturbations because of the restriction imposed by time averaging (i.e. mean clearances, half-lives and volumes are produced). Systematic studies of pharmacokinetic properties of perfusion-limited drugs such as chlormethiazole must be developed in such a way as to allow for independent variation of flow and extraction.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7295462      PMCID: PMC1401788          DOI: 10.1111/j.1365-2125.1981.tb01220.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  The pharmacokinetics of chlormethiazole following intravenous administration in the aged.

Authors:  R L Nation; B Learoyd; J Barber; E J Triggs
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

2.  Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

3.  Controlled trial of chlormethiazole in treatment of the alcoholic withdrawal phase.

Authors:  M M GLATT; H R GEORGE; E P FRISCH
Journal:  Br Med J       Date:  1965-08-14

4.  Pharmacokinetics of chlormethiazole in humans.

Authors:  R G Moore; E J Triggs; C A Shanks; J Thomas
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

5.  Chlormethiazole in the prevention of eclampsia and the reduction of perinatal mortality.

Authors:  G M Duffus; M E Tunstall; R G Condie; I MacGillivray
Journal:  J Obstet Gynaecol Br Commonw       Date:  1969-07

6.  Chlormethiazole (Hemineurin) infusion as supplemental sedation during epidural block.

Authors:  S A Schweitzer
Journal:  Anaesth Intensive Care       Date:  1978-08       Impact factor: 1.669

7.  The effects of age and liver disease on the disposition and elimination of diazepam in adult man.

Authors:  U Klotz; G R Avant; A Hoyumpa; S Schenker; G R Wilkinson
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

8.  Intravenous sedation and regional analgesia.

Authors:  J Gjessing; P J Tomlin
Journal:  Anaesthesia       Date:  1977-01       Impact factor: 6.955

9.  Kinetics of chlormethiazole in patients with alcohol withdrawal manifestations.

Authors:  K G Jostell; S Agurell; L E Hollister; B Wermuth
Journal:  Clin Pharmacol Ther       Date:  1978-02       Impact factor: 6.875

10.  Pharmacokinetics of clomethiazole in healthy adults.

Authors:  K G Jostell; S Agurell; L G Allgén; B Kuylenstierna; J E Lindgren; G Aberg; G Osterlöf
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1978-09
View more
  2 in total

1.  Determination of pharmacokinetic constants after multiple infusions of drugs.

Authors:  L E Mather; R L Ringrose; K L Austin
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

2.  A physiologically-based recirculatory meta-model for nasal fentanyl in man.

Authors:  Richard N Upton; David J R Foster; Lona L Christrup; Ola Dale; Kristin Moksnes; Lars Popper
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-08-19       Impact factor: 2.745

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.